Complement-Mediated Cellular Injury

Seminars in Nephrology

Volumn 33, Issue 6, 2013, Pages 586-601

  Takano, Tomoko ^a   Elimam, Hanan ^a   Cybulsky, Andrey V ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

C5b 9 membrane attack complex; Cytoskeleton; Glomerulonephritis; Phospholipases; Protein kinases

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C5A; COMPLEMENT MEMBRANE ATTACK COMPLEX; GROWTH FACTOR; MESSENGER RNA; NEPHRIN; PHOSPHOLIPASE A2; PROSTANOID; PROTEASOME; PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; UBIQUITIN;

ACUTE KIDNEY FAILURE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE REGULATION; CELL DAMAGE; CELL PROLIFERATION; COMPLEMENT ACTIVATION; CYTOSKELETON; DNA DAMAGE; ECTOCYTOSIS; ENDOCYTOSIS; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEMOLYTIC UREMIC SYNDROME; HUMAN; KIDNEY ISCHEMIA; MEMBRANE BIOLOGY; MEMBRANOUS GLOMERULONEPHRITIS; MESANGIUM CELL; NEPHRIN GENE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UBIQUITINATION; UPREGULATION;

C5B-9 MEMBRANE ATTACK COMPLEX; CYTOSKELETON; GLOMERULONEPHRITIS; PHOSPHOLIPASES; PROTEIN KINASES;

ANIMALS; CELL MEMBRANE; COMPLEMENT ACTIVATION; COMPLEMENT MEMBRANE ATTACK COMPLEX; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; KIDNEY DISEASES; KIDNEY GLOMERULUS; PHOSPHOLIPASES; PODOCYTES; PROTEIN KINASES; RATS;

EID: 84886285239     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2013.08.009     Document Type: Article

References (104)

1. Tegla C.A., Cudrici C., Patel S., et al. Membrane attack by complement: the assembly and biology of terminal complement complexes. Immunol Res 2011, 51:45-60.
2. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat Immunol 2010, 11:785-797.
3. Leslie M. Immunology. The new view of complement. Science 2012, 337:1034-1037.
4. Berger S.P., Daha M.R. Complement in glomerular injury. Semin Immunopathol 2007, 29:375-384.
5. Quigg R.J. Complement and the kidney. J Immunol 2003, 171:3319-3324.
6. Cybulsky A.V., Quigg R.J., Salant D.J. Experimental membranous nephropathy redux. Am J Physiol Renal Physiol 2005, 289:F660-F671.
7. Cybulsky A.V. Membranous nephropathy. Contrib Nephrol 2011, 169:107-125.
8. Nangaku M., Shankland S.J., Couser W.G. Cellular response to injury in membranous nephropathy. J Am Soc Nephrol 2005, 16:1195-1204.
9. Couser W.G. Complement inhibitors and glomerulonephritis: are we there yet?. J Am Soc Nephrol 2003, 14:815-818.
10. Morgan B.P. Effects of the membrane attack complex of complement on nucleated cells. Curr Top Microbiol Immunol 1992, 178:115-140.
11. Nicholson-Weller A., Halperin J.A. Membrane signaling by complement C5b-9, the membrane attack complex. Immunol Res 1993, 12:244-257.
12. Bohana-Kashtan O., Ziporen L., Donin N., Kraus S., Fishelson Z. Cell signals transduced by complement. Mol Immunol 2004, 41:583-597.
13. Chen Z.H., Qin W.S., Zeng C.H., et al. Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro. Kidney Int 2010, 77:974-988.
14. Koshikawa M., Mukoyama M., Mori K., et al. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J Am Soc Nephrol 2005, 16:2690-2701.
15. Ren G., Huynh C., Bijian K., Cybulsky A.V. Role of apoptosis signal-regulating kinase 1 in complement-mediated glomerular epithelial cell injury. Mol Immunol 2008, 45:2236-2246.
16. David S., Biancone L., Caserta C., Bussolati B., Cambi V., Camussi G. Alternative pathway complement activation induces proinflammatory activity in human proximal tubular epithelial cells. Nephrol Dial Transplant 1997, 12:51-56.
17. Cohen D., Papillon J., Aoudjit L., Li H., Cybulsky A.V., Takano T. Role of calcium-independent phospholipase A2 in complement-mediated glomerular epithelial cell injury. Am J Physiol Renal Physiol 2008, 294:F469-F479.
18. Elimam H., Papillon J., Takano T., Cybulsky A.V. Complement-mediated activation of calcium-independent phospholipase A2gamma: role of protein kinases and phosphorylation. J Biol Chem 2013, 288:3871-3885.
19. Takano T., Cybulsky A.V., Cupples W.A., Ajikobi D.O., Papillon J., Aoudjit L. Inhibition of cyclooxygenases reduces complement-induced glomerular epithelial cell injury and proteinuria in passive Heymann nephritis. J Pharmacol Exp Ther 2003, 305:240-249.
20. Weise W.J., Natori Y., Levine J.S., et al. Fish oil has protective and therapeutic effects on proteinuria in passive Heymann nephritis. Kidney Int 1993, 43:359-368.
21. Adler S., Baker P.J., Johnson R.J., Ochi R.F., Pritzl P., Couser W.G. Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest 1986, 77:762-767.
22. Biancone L., David S., Della Pietra V., Montrucchio G., Cambi V., Camussi G. Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. Kidney Int 1994, 45:451-460.
23. Neale T.J., Ojha P.P., Exner M., et al. Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen. J Clin Invest 1994, 94:1577-1584.
24. Gwinner W., Plasger J., Brandes R.P., et al. Role of xanthine oxidase in passive Heymann nephritis in rats. J Am Soc Nephrol 1999, 10:538-544.
25. Liu H., Tian N., Arany I., et al. Cytochrome P450 2B1 mediates complement-dependent sublytic injury in a model of membranous nephropathy. J Biol Chem 2010, 285:40901-40910.
26. Tryggvason K., Patrakka J., Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 2006, 354:1387-1401.
27. Peng H., Takano T., Papillon J., Bijian K., Khadir A., Cybulsky A.V. Complement activates the c-Jun N-terminal kinase/stress-activated protein kinase in glomerular epithelial cells. J Immunol 2002, 169:2594-2601.
28. Gaertner S.A., Janssen U., Ostendorf T., Koch K.M., Floege J., Gwinner W. Glomerular oxidative and antioxidative systems in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol 2002, 13:2930-2937.
29. Budisavljevic M.N., Hodge L., Barber K., et al. Oxidative stress in the pathogenesis of experimental mesangial proliferative glomerulonephritis. Am J Physiol Renal Physiol 2003, 285:F1138-F1148.
30. Gao L., Qiu W., Wang Y., Xu W., Xu J., Tong J. Sublytic complement C5b-9 complexes induce thrombospondin-1 production in rat glomerular mesangial cells via PI3-k/Akt: association with activation of latent transforming growth factor-beta1. Clin Exp Immunol 2006, 144:326-334.
31. Floege J., Eitner F., Alpers C.E. A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 2008, 19:12-23.
32. Shankland S.J. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006, 69:2131-2147.
33. Mudge S.J., Paizis K., Auwardt R.B., Thomas R.J., Power D.A. Activation of nuclear factor-kappa B by podocytes in the autologous phase of passive Heymann nephritis. Kidney Int 2001, 59:923-931.
34. Hussain S., Romio L., Saleem M., et al. Nephrin deficiency activates NF-{kappa}B and promotes glomerular injury. J Am Soc Nephrol 2009, 20:1733-1743.
35. Kilgore K.S., Schmid E., Shanley T.P., et al. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Am J Pathol 1997, 150:2019-2031.
36. Gancz D., Lusthaus M., Fishelson Z. A role for the NF-kappaB pathway in cell protection from complement-dependent cytotoxicity. J Immunol 2012, 189:860-866.
37. Pippin J.W., Durvasula R., Petermann A., Hiromura K., Couser W.G., Shankland S.J. DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes. J Clin Invest 2003, 111:877-885.
38. Kim S.H., Carney D.F., Hammer C.H., Shin M.L. Nucleated cell killing by complement: effects of C5b-9 channel size and extracellular Ca2+ on the lytic process. J Immunol 1987, 138:1530-1536.
39. Moskovich O., Fishelson Z. Live cell imaging of outward and inward vesiculation induced by the complement c5b-9 complex. J Biol Chem 2007, 282:29977-29986.
40. Kerjaschki D., Schulze M., Binder S., et al. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J Immunol 1989, 143:546-552.
41. Cybulsky A.V. Endoplasmic reticulum stress in proteinuric kidney disease. Kidney Int 2010, 77:187-193.
42. Cybulsky A.V. The intersecting roles of endoplasmic reticulum stress, ubiquitin- proteasome system, and autophagy in the pathogenesis of proteinuric kidney disease. Kidney Int 2013, 84:25-33.
43. Cybulsky A.V., Takano T., Papillon J., Khadir A., Liu J., Peng H. Complement C5b-9 membrane attack complex increases expression of endoplasmic reticulum stress proteins in glomerular epithelial cells. J Biol Chem 2002, 277:41342-41351.
44. Wang L., Hong Q., Lv Y., et al. Autophagy can repair endoplasmic reticulum stress damage of the passive Heymann nephritis model as revealed by proteomics analysis. J Proteomics 2012, 75:3866-3876.
45. Inagi R., Kumagai T., Nishi H., et al. Preconditioning with endoplasmic reticulum stress ameliorates mesangioproliferative glomerulonephritis. J Am Soc Nephrol 2008, 19:915-922.
46. Meyer-Schwesinger C., Meyer T.N., Sievert H., et al. Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy. Am J Pathol 2011, 178:2044-2057.
47. Kitzler T.M., Papillon J., Guillemette J., Wing S.S., Cybulsky A.V. Complement modulates the function of the ubiquitin-proteasome system and endoplasmic reticulum-associated degradation in glomerular epithelial cells. Biochim Biophys Acta 2012, 1823:1007-1016.
48. Meyer-Schwesinger C., Meyer T.N., Munster S., et al. A new role for the neuronal ubiquitin C-terminal hydrolase-L1 (UCH-L1) in podocyte process formation and podocyte injury in human glomerulopathies. J Pathol 2009, 217:452-464.
49. Hauser P.V., Perco P., Muhlberger I., et al. Microarray and bioinformatics analysis of gene expression in experimental membranous nephropathy. Nephron Exp Nephrol 2009, 112:e43-58.
50. Topham P.S., Haydar S.A., Kuphal R., Lightfoot J.D., Salant D.J. Complement-mediated injury reversibly disrupts glomerular epithelial cell actin microfilaments and focal adhesions. Kidney Int 1999, 55:1763-1775.
51. Zhang H., Cybulsky A.V., Aoudjit L., et al. Role of Rho-GTPases in complement-mediated glomerular epithelial cell injury. Am J Physiol Renal Physiol 2007, 293:F148-F156.
52. Zhu L., Jiang R., Aoudjit L., Jones N., Takano T. Activation of RhoA in podocytes induces focal segmental glomerulosclerosis. J Am Soc Nephrol 2011, 22:1621-1630.
53. Huynh C., Ren G., Papillon J., Guillemette J., Takano T., Cybulsky A.V. The cytoprotective role of Ras in complement-mediated glomerular epithelial cell injury. Clin Immunol 2009, 131:343-353.
54. Moller C.C., Wei C., Altintas M.M., et al. Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol 2007, 18:29-36.
55. Nakatsue T., Koike H., Han G.D., et al. Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy. Kidney Int 2005, 67:2239-2253.
56. Li H., Lemay S., Aoudjit L., Kawachi H., Takano T. Src-family kinase Fyn phosphorylates the cytoplasmic domain of nephrin and modulates its interaction with podocin. J Am Soc Nephrol 2004, 15:3006-3015.
57. Wagner C., Braunger M., Beer M., Rother K., Hansch G.M. Induction of matrix protein synthesis in human glomerular mesangial cells by the terminal complement complex. Exp Nephrol 1994, 2:51-56.
58. Brandt J., Pippin J., Schulze M., et al. Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis. Kidney Int 1996, 49:335-343.
59. Shankland S.J., Pippin J., Pichler R.H., et al. Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy. Kidney Int 1996, 50:116-124.
60. Rangan G.K., Pippin J.W., Couser W.G. C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis. Kidney Int 2004, 66:1838-1848.
61. Abe K., Li K., Sacks S.H., Sheerin N.S. The membrane attack complex, C5b-9, up regulates collagen gene expression in renal tubular epithelial cells. Clin Exp Immunol 2004, 136:60-66.
62. Abbate M., Zoja C., Corna D., et al. Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury. J Am Soc Nephrol 2008, 19:1158-1167.
63. Gaarkeuken H., Siezenga M.A., Zuidwijk K., et al. Complement activation by tubular cells is mediated by properdin binding. Am J Physiol Renal Physiol 2008, 295:F1397-F1403.
64. Shankland S.J., Pippin J.W., Couser W.G. Complement (C5b-9) induces glomerular epithelial cell DNA synthesis but not proliferation in vitro. Kidney Int 1999, 56:538-548.
65. Rus H.G., Niculescu F.I., Shin M.L. Role of the C5b-9 complement complex in cell cycle and apoptosis. Immunol Rev 2001, 180:49-55.
66. Qiu W., Zhang Y., Liu X., et al. Sublytic C5b-9 complexes induce proliferative changes of glomerular mesangial cells in rat Thy-1 nephritis through TRAF6-mediated PI3K-dependent Akt1 activation. J Pathol 2011, 226:619-632.
67. Fosbrink M., Niculescu F., Rus V., Shin M.L., Rus H. C5b-9-induced endothelial cell proliferation and migration are dependent on Akt inactivation of forkhead transcription factor FOXO1. J Biol Chem 2006, 281:19009-19018.
68. Soane L., Cho H.J., Niculescu F., Rus H., Shin M.L. C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway. J Immunol 2001, 167:2305-2311.
69. Cudrici C., Niculescu F., Jensen T., et al. C5b-9 terminal complex protects oligodendrocytes from apoptotic cell death by inhibiting caspase-8 processing and up-regulating FLIP. J Immunol 2006, 176:3173-3180.
70. Nauta A.J., Daha M.R., Tijsma O., van de Water B., Tedesco F., Roos A. The membrane attack complex of complement induces caspase activation and apoptosis. Eur J Immunol 2002, 32:783-792.
71. Hughes J., Nangaku M., Alpers C.E., Shankland S.J., Couser W.G., Johnson R.J. C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis. Am J Physiol Renal Physiol 2000, 278:F747-F757.
72. Ziporen L., Donin N., Shmushkovich T., Gross A., Fishelson Z. Programmed necrotic cell death induced by complement involves a Bid-dependent pathway. J Immunol 2009, 182:515-521.
73. Roos A., Sato T., Maier H., van Kooten C., Daha M.R. Induction of renal cell apoptosis by antibodies and complement. Exp Nephrol 2001, 9:65-70.
74. Jiang X., Zhang J., Xia M., et al. Role of activating transcription factor 3 (ATF3) in sublytic C5b-9-induced glomerular mesangial cell apoptosis. Cell Mol Immunol 2010, 7:143-151.
75. Xu K., Zhou Y., Qiu W., et al. Activating transcription factor 3 (ATF3) promotes sublytic C5b-9-induced glomerular mesangial cells apoptosis through up-regulation of Gadd45α and KLF6 gene expression. Immunobiology 2011, 216:871-881.
76. Liu L., Qiu W., Wang H., et al. Sublytic C5b-9 complexes induce apoptosis of glomerular mesangial cells in rats with Thy-1 nephritis through role of interferon regulatory factor-1-dependent caspase 8 activation. J Biol Chem 2012, 287:16410-16423.
77. Mudge S.J., McRae J.L., Auwardt R.B., Murphy B.F., Chen C.G., Power D.A. Sublytic complement injury does not activate NF-kappa B, or induce mitogenesis in rat mesangial cells. Exp Nephrol 2000, 8:291-298.
78. Guo R.F., Huber-Lang M., Wang X., et al. Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. J Clin Invest 2000, 106:1271-1280.
79. Pasinetti G.M., Tocco G., Sakhi S., et al. Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative responses that implicate new roles for the C-system in neuronal and astrocytic functions. Neurobiol Dis 1996, 3:197-204.
80. Osaka H., Mukherjee P., Aisen P.S., Pasinetti G.M. Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity. J Cell Biochem 1999, 73:303-311.
81. Perianayagam M.C., Balakrishnan V.S., King A.J., Pereira B.J., Jaber B.L. C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway. Kidney Int 2002, 61:456-463.
82. Welch T.R., Frenzke M., Witte D., Davis A.E. C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritis. Clin Exp Immunol 2002, 130:43-48.
83. Zahedi R., Braun M., Wetsel R.A., et al. The C5a receptor is expressed by human renal proximal tubular epithelial cells. Clin Exp Immunol 2000, 121:226-233.
84. Pickering M.C., Cook H.T., Warren J., et al. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 2002, 31:424-428.
85. Pickering M.C., Warren J., Rose K.L., et al. Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proc Natl Acad Sci U S A 2006, 103:9649-9654.
86. Sato T., van Dixhoorn M.G., Schroeijers W.E., van Es L.A., Daha M.R. Efficient induction of apoptosis in cultured rat glomerular mesangial cells by dimeric monoclonal IgA anti-Thy-1 antibodies. Kidney Int 1997, 51:173-181.
87. Bordin S., Whitfield D. Cutting edge: proliferating fibroblasts respond to collagenous C1q with phosphorylation of p38 mitogen-activated protein kinase and apoptotic features. J Immunol 2003, 170:667-671.
88. Nangaku M., Shankland S.J., Couser W.G., Johnson R.J. A new model of renal microvascular injury. Curr Opin Nephrol Hypertens 1998, 7:457-462.
89. Kavanagh D., Goodship T.H. Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations. Hematology Am Soc Hematol Educ Program 2011, 2011:15-20.
90. Vernon K.A., Cook H.T. Complement in glomerular disease. Adv Chronic Kidney Dis 2012, 19:84-92.
91. Morigi M., Galbusera M., Gastoldi S., et al. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J Immunol 2011, 187:172-180.
92. Lapeyraque A.L., Malina M., Fremeaux-Bacchi V., et al. Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med 2011, 364:2561-2563.
93. Carter A.M. Complement activation: an emerging player in the pathogenesis of cardiovascular disease. Scientifica 2012, 2012:14.
94. Bonventre J.V. Complement and renal ischemia-reperfusion injury. Am J Kidney Dis 2001, 38:430-436.
95. Zhou W., Farrar C.A., Abe K., et al. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 2000, 105:1363-1371.
96. de Vries B., Kohl J., Leclercq W.K., et al. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J Immunol 2003, 170:3883-3889.
97. Peng Q., Li K., Smyth L.A., et al. C3a and C5a promote renal ischemia-reperfusion injury. J Am Soc Nephrol 2012, 23:1474-1485.
98. Miwa T., Sato S., Gullipalli D., Nangaku M., Song W.-C. Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice. J Immunol 2013, 190:3552-3559.
99. Amura C.R., Renner B., Lyubchenko T., Faubel S., Simonian P.L., Thurman J.M. Complement activation and toll-like receptor-2 signaling contribute to cytokine production after renal ischemia/reperfusion. Mol Immunol 2012, 52:249-257.
100. Pan H., Shen Z., Mukhopadhyay P., et al. Anaphylatoxin C5a contributes to the pathogenesis of cisplatin-induced nephrotoxicity. Am J Physiol Renal Physiol 2009, 296:F496-F504.
101. van Werkhoven M.B., Damman J., Daha M.R., et al. Novel insights in localization and expression levels of C5aR and C5L2 under native and post-transplant conditions in the kidney. Mol Immunol 2013, 53:237-245.
102. Cunningham P.N., Quigg R.J. Contrasting roles of complement activation and its regulation in membranous nephropathy. J Am Soc Nephrol 2005, 16:1214-1222.
103. Risitano A.M., Notaro R., Pascariello C., et al. The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment. Blood 2012, 119:6307-6316.
104. Cybulsky A.V., Takano T., Papillon J., Bijian K. Role of the endoplasmic reticulum unfolded protein response in glomerular epithelial cell injury. J Biol Chem 2005, 280:24396-24403.